Sestrin 2 suppresses cells proliferation through AMPK/mTORC1 pathway activation in colorectal cancer

Jin-Lai Wei1, Min Fang2, Zhong-Xue Fu1

  • 1Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.

Oncotarget
|May 20, 2017
PubMed

Insights

Sestrin 2, an antioxidant protein, suppresses colorectal cancer (CRC) growth by reducing reactive oxygen species (ROS) and activating the AMPK/mTORC1 pathway. Overexpression of sestrin 2 inhibits CRC cell proliferation and promotes apoptosis, suggesting its potential as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Sestrin 2 is an antioxidant protein known to reduce reactive oxygen species (ROS) and inhibit mammalian target of rapamycin complex 1 (mTORC1).
  • Previous studies indicated that sestrin 2 levels are abnormally decreased in colorectal cancer (CRC).

Purpose of the Study:

  • To investigate the molecular mechanisms by which sestrin 2 influences colorectal cancer progression.
  • To determine the effects of sestrin 2 overexpression on human CRC cell lines and a xenograft mouse model.

Main Methods:

  • Utilized a lentiviral expression vector system for sestrin 2 overexpression in human CRC cells.
  • Assessed changes in ROS production, cell proliferation (PCNA), apoptosis (caspases, survivin), and signaling pathways (AMPK, mTORC1).
  • Employed compound C (AMPK inhibitor) and a xenograft mouse model to validate findings.

Main Results:

  • Sestrin 2 overexpression decreased ROS production, inhibited CRC cell growth, and stimulated apoptosis.
  • Increased levels of proapoptotic proteins (caspase 3, 7, 9) and decreased levels of anti-apoptotic protein survivin were observed.
  • Sestrin 2 activated the AMPK pathway, suppressed mTORC1 signaling, and attenuated CRC growth in vivo.

Conclusions:

  • Sestrin 2 suppresses colorectal cancer growth via AMPK/mTORC1 pathway activation and apoptosis induction.
  • Sestrin 2 represents a potential novel pharmacological target for CRC treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K